Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4996147

CN(C)c1ccc(-c2cc(-c3cc4n(n3)CCNC4=O)ccn2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.52
ABL1 P00519 3/20 0.37
BCR P11274 3/20 0.37
PIK3C3 Q8NEB9 2/20 0.36
MAPKAPK2 P49137 7/20 0.35
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
FYN P06241 2/20 0.34
ASIC1 P78348 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
GLA P06280 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BRAF P15056 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4717244 0.94 CDC7 (0.45) CDC7ABL1BCRPIK3C3MAPKAPK2
SCHEMBL4717758 0.91 CDC7 (0.62) CDC7ABL1BCRPIK3C3MAPKAPK2
Trifluoroacetic Acid SCHEMBL4997521 0.87 CDC7 (0.55) CDC7ABL1BCRPIK3C3MAPKAPK2
Trifluoroacetic Acid SCHEMBL4790707 0.87 CDC7 (0.52) CDC7ABL1BCRPIK3C3MAPKAPK2
Trifluoroacetic Acid SCHEMBL4997167 0.86 CDC7 (0.53) CDC7PIK3C3PIM1PIM2ASIC1
Trifluoroacetic Acid SCHEMBL5000129 0.86 CDC7 (0.53) CDC7ABL1BCRPIK3C3MAPKAPK2
Trifluoroacetic Acid SCHEMBL4716136 0.85 CDC7 (0.52) CDC7PIK3C3MAPKAPK2PIM1PIM2
SCHEMBL4716236 0.85 CDC7 (0.53) CDC7ABL1BCRPIK3C3MAPKAPK2
Trifluoroacetic Acid SCHEMBL4715188 0.85 CDC7 (0.52) CDC7ABL1KDM5AKDM4CKDM5B
Trifluoroacetic Acid SCHEMBL4713069 0.85 CDC7 (0.51) CDC7PIK3C3MAPKAPK2PIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20040152739-A1 Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2 PHARMACIA CORPORATION 2004-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885ABL1 563/4885BCR 3771/4885
US-20040152739-A1 Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2 MAPKAPK2, MAP3K2, MAP4K2 CDC7 331/4885ABL1 587/4885BCR 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.